PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 24.45
-2.20 (-8.26%)
Mar 13, 2026, 4:14 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 879.22 million as of March 13, 2026. Its market cap has increased by 19.27% in one year.
Market Cap
879.22M
Enterprise Value
911.56M
Revenue
364.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.45
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 879.22M, a decrease of -66.06%. That is a compound annual growth rate of -19.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 879.22M | 2.11% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.71B |
| Novartis AG | 231.34B |
| Galderma Group AG | 35.42B |
| Lonza Group AG | 34.38B |
| Cosmo Pharmaceuticals | 1.46B |
| Aevis Victoria | 1.17B |
| SKAN Group AG | 1.12B |
| Medartis Holding AG | 1.02B |